Sign In
Buy CRSP
$52.08
+0.0600 (+0.115%)
At Close: Jun 03, 2026
CRISPR Therapeutics AG (CRSP) is Attracting Investor Attention: Here is What You Should Know
10:00am, Tuesday, 11'th Jun 2024
CRISPR Therapeutics (CRSP) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Cathie Wood Goes Bargain Hunting: 2 Stocks She Just Bought
06:20am, Sunday, 09'th Jun 2024
Cathie Wood loves bargains on potential long-term winners -- especially when the company is an innovator. One of her favorite technologies in healthcare is gene editing, and she's been loading up on t
The 'Undercovered' Dozen From June 1-6
06:26pm, Friday, 07'th Jun 2024
The "Undercovered" Dozen highlights twelve ideas from the previous month on stocks with limited coverage. Biotechs CRISPR Therapeutics, Voyager Therapeutics, and Alnylam Pharmaceuticals are covered al
Why Is CRISPR Therapeutics (CRSP) Up 12% Since Last Earnings Report?
12:36pm, Friday, 07'th Jun 2024
CRISPR Therapeutics (CRSP) reported earnings 30 days ago. What's next for the stock?
CRISPR Therapeutics AG (CRSP) Jefferies 2024 Global Healthcare Conference (Transcript)
12:40am, Thursday, 06'th Jun 2024
CRISPR Therapeutics AG (NASDAQ:CRSP ) Jefferies 2024 Global Healthcare Conference June 5, 2024 10:00 AM ET Company Participants Samarth Kulkarni - Chief Executive Officer Conference Call Participants
Cathie Wood Is Buying the Dip on These 2 Biotech Stocks. Should You?
06:45am, Tuesday, 04'th Jun 2024
Buying the dip in a promising stock can be an effective strategy. CRISPR Therapeutics has a long way to go before becoming profitable.
7 Stocks You Haven't Heard of (That EVERYONE Should Own)
04:30pm, Wednesday, 29'th May 2024
There are many must-own stocks beyond the mega-caps that aren't household names but have solid potential going forward. These stocks are using megatrends and tailwinds and have solid upside catalysts
CRISPR Therapeutics AG (CRSP) Is a Trending Stock: Facts to Know Before Betting on It
10:01am, Wednesday, 29'th May 2024
CRISPR Therapeutics (CRSP) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
CRISPR Therapeutics to Participate in Upcoming Investor Conferences
08:00am, Wednesday, 29'th May 2024
ZUG, Switzerland and BOSTON, May 29, 2024 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseas
7 Biotech Stocks to Put on Your Breakthrough Radar
12:32pm, Monday, 27'th May 2024
For those seeking to decipher best speculative opportunities in the market, biotech stocks with breakthrough potential may offer plenty of firepower. Let's get some of the bad stuff out of the way fir
3 Reasons to Buy CRISPR Therapeutics Stock Like There's No Tomorrow
09:15am, Sunday, 26'th May 2024
CRISPR Therapeutics is in the process of launching its first medicine. It has plenty of cash, no debt, and manageable expenses.
Final Trade: UAL, NKE, SLV & CRSP
07:40pm, Friday, 24'th May 2024
The final trades of the day with CNBC's Melissa Lee and the Option Action traders.
CRISPR Therapeutics Strengthens Executive Leadership Team with Key Appointments
08:00am, Thursday, 23'rd May 2024
-Naimish Patel, M.D., appointed to Chief Medical Officer- -Julianne Bruno, M.B.A.
7 Must-Buy Stocks if You Only Have $1,000 to Spend: May Edition
09:22am, Wednesday, 22'nd May 2024
If you have a budget of around $1,000 and you'd like to buy some solid stocks to beat the market, I've got you covered! The stocks in this article total around ~$383 as of writing if you bought one of
Is CRISPR Therapeutics a Millionaire Maker?
09:10am, Wednesday, 22'nd May 2024
CRISPR Therapeutics is finally at the cusp of profitability. Its pipeline has quite a few promising opportunities beyond the approved therapies.
